Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19

Mesenchymal stem cells (MSC) have received particular attention due to their ability to inhibit inflammation caused by cytokine storm induced by COVID-19. In this way some patients have been treated successfully. The aim of this study was to evaluate the safety and describe the clinical changes afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Iglesias, Martin, Butrón, Patricia, Torre-Villalvazo, Iván, Torre-Anaya, Erik A, Sierra-Madero, Juan, Rodriguez-Andoney, José J, Tovar-Palacio, Armando R, Zentella-Dehesa, Alejandro, Domínguez-Cherit, Guillermo, Rodriguez-Reyna, Tatiana S, Granados-Arriola, Julio, Espisosa-Cruz, Verónica, Téllez-Pallares, Fernando P, Lozada-Estrada, Alexia, Zepeda Carrillo, Carol A, Vázquez-Mézquita, Aldo J, Nario-Chaidez, Hector F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2021
Materias:
Orginal Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990366/
https://www.ncbi.nlm.nih.gov/pubmed/33815870
http://dx.doi.org/10.14336/AD.2020.1218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990366/
https://www.ncbi.nlm.nih.gov/pubmed/33815870
http://dx.doi.org/10.14336/AD.2020.1218

Ejemplares similares